Surveillance for vancomycin resistant enterococci in a tertiary institution in South Western Nigeria

African Journal of Infectious Diseases

Volumn 10, Issue 2, 2016, Pages 121-126

  Ekuma, Agantem Emmanuel ^a   Oduyebo, Oyin O ^b   Efunshile, Akinwale Michael ^c,d   Konig, Brigitte ^d  

^a UNIVERSITY OF CALABAR   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

^c EBONYI STATE UNIVERSITY   (Nigeria)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Enterococcus; Resistance; Vancomycin; VRE

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLONE; TEICOPLANIN; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CHILD; DISEASE SURVEILLANCE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; EPSILOMETER TEST; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NIGERIA; NONHUMAN; POLYMERASE CHAIN REACTION; SPECIES IDENTIFICATION; TERTIARY HEALTH CARE; VANCOMYCIN RESISTANT ENTEROCOCCAL INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84964872644     PISSN: 20060165     EISSN: None     Source Type: Journal    
DOI: 10.21010/ajid.v10i2.8     Document Type: Article

References (27)

1. Iregbu K, Ogunsola F, Odugbemi T. (2002). Susceptibility profile of Enterococcus faecalis isolated at the Lagos University Teaching Hospital, Nigeria. Niger Postgrad Med J.;9(3):125-8.
2. Olawale KO, Fadiora SO, Taiwo SS. (2011). Prevalence of Hospital-Acquired Enterococci Infections in two Primary-Care Hospitals in Osogbo, Southwestern Nigeria. African J Infect Dis.;5(2):40-6.
3. David OM, Oluduro AO, Olawale AK, Osuntoyinbo RT, Olowe OA, Famurewa O. (2010). Incidence of Multiple Antibiotic Resistance and Plasmid Carriage among Enterococcus faecalis Isolated from the Hands of Health Care Workers in Selected Hospitals in Ekiti, Ondo and Osun States, Nigeria. Int J Acad Res.;2(1):43-7.
4. Mundy, L. M., Sahm, D. F., Gilmore M. (2000). Relationships between Enterococcal Virulence and Antimicrobial Resistance. Clin Microbiol Rev.;13(4):513.
5. Centers for Disease Control and Prevention. (1995). Recommendations for preventing spread of Vancomycin resistance. Infect Control Hosp Epidemiol.;16:105-13.
6. Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, Sundsfjord A, Pruzzo, C, Donelli, G. (2007). VanA-Type Enterococci from Humans, Animals, and Food: Species Distribution, Population Structure, Tn 1546 Typing and Location, and Virulence Determinants. Appl Environ Microbiol.;73(10):3307-19.
7. Murray PR. (2012). What Is New in Clinical Microbiology-Microbial Identification by MALDI-TOF Mass Spectrometry. JMDI [Internet]. Elsevier Inc.;;14(5):419-23.
8. Clinical and Laboratory Standards Institute. (2011). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. 31st ed.
9. Sakai E, Mori M, Nakagawara K. (2002). Automated DNA Isolation from Genetically Modified Soybeans and Soybean Derived Food Material with the MagNA Pure LC System. Biochemica.1:16-7.
10. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao, J D C, Wengenack, N L, Cockerill, F R, Smith, T F (2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin Microbiol Rev.19(1):165-256.
11. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare, I, Kristinsson, K G (2008). Emergence and spread of vancomycin resistance among Enterococci in Europe. Eurosurveillance.13(42):1-11.
12. Arias CA, Contreras GA, Murray BE. (2010). Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect.16(6):555-62.
13. Cetinkaya Y, Falk P, Mayhall CG. (2000). Vancomycin-Resistant Enterococci. Clin Microbiol Rev.13(4):686-707.
14. Bazuaye N, Nwogoh B, Ikponmwen D, Irowa O, Okugbo S, Isa I, Ighodaro, Emmanuel, Aina, Yetunde-Isreal, Osaguona, Anthony, Idemudia, Osagie, Iyoha, Osaretin, Ighosewe, Okiroro, Osaghae, Dominic, Bucher, Christoph (2013). First successful allogeneic hematopoietic stem cell transplantation for a sickle cell disease patient in a low resource country (Nigeria): a case report. Ann Transplant;19:210-3.
15. Arogundade FA. Kidney transplantation in a low-resource setting: Nigeria experience. Kidney International Suppl. (2013) 3(2):241-5.
16. Adamu B. (2015). Peculiarities of tuberculosis in kidney transplant recipients. Ann Afr Med. 12(3):143-7.
17. Gottberg A V., Nierop W V., Dusé A, Kassel M, McCarthy K, Brink A, Meyers, M., Smego, R., Koornhof, H. (2000). Epidemiology of Glycopeptide-Resistant Enterococci Colonizing High-Risk Patients in Hospitals in Johannesburg, Republic of South Africa. J Clin Microbiol.38(2):905.
18. Harbarth S, Cosgrove S, Carmeli Y, Enterococci V. (2002). Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci. Antimicrob Agents Chemother.46(6):1619-28.
19. Quintiliani R, Courvalin P. (1994). Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett. 119:359-63.
20. Boyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., Medeiros AA. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994
21. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. (2001). Possible Horizontal Transfer of the vanB2 Gene among Genetically Diverse Strains of Vancomycin-Resistant Enterococcus faecium in a Korean Hospital. J Clin Microbiol. 39(3):1165-8.
22. Jombo GT, Egah DZ, Banwat EB, Ayeni JA. (2006). Nosocomial and community acquired UTIs at a teaching hospital in north central Nigeria: Finding from a study of 12,458 urine samples. Niger J Med. 15(3):230-6.
23. Torell E, Cars O, Olsson-liljequist B, Lindbäck J, Burman LG, Hoffman B. (1999). Near Absence of Vancomycin-Resistant Enterococci but High Carriage Rates of Quinolone-Resistant Ampicillin-Resistant Enterococci among Hospitalized Patients and Nonhospitalized Individuals in Sweden. J Clin Microbiol. 37(11):3509-13.
24. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook, P., Wormser, G. P. (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother.38:1363-7.
25. Panesso D, Reyes J, Rincón S, Galloway-peña J, Zurita J, Merentes A, Guzmán, M, Javier, A, Murray, B E, Arias, C A, Rinco, S, Díaz, L, Galloway-pen, J. (2010). Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium: a Prospective, Multicenter Study in South American Hospitals. J Clin Microbiol. 48(5):1562-9.
26. Mclaughlin M, Malczynski M, Qi C, Radetski J, Zembower T, Marc H, Barajas, G, Scheetz, H (2013). Virulence of Vancomycin-Resistant Enterococcus faecium According to Linezolid Resistance and Clinical Outbreak Status. Antimicrob Agents Chemother.57(8):3923-7.
27. Hayakawa K, Marchaim D, Pall M, Gudur uma mahesh, Pulluru H, Bathina P, Alshabani, K, Govindavarjhulla, A, Mallad, A, Abbadi, D R, Chowdary, D, Kakarlapudi, H, Guddati, H, Das, M, Kannekanti, N, Diviti, S, Sukayogula, K, Joseph, M, Pogue, J M, Lephart, P R, Martin, E T, Rybak, M J, Kaye, K S. (2013). Epidemiology of Vancomycin-Resistant Enterococcus faecalis: a Case-Case-Control Study. Antimicrob Agents Chemother.57(1):49-55.